273 related articles for article (PubMed ID: 25444864)
1. Effect of insulin deficiency on the rewarding properties of methamphetamine in streptozotocin-induced diabetic rats.
Bayat AH; Haghparast A
Pharmacol Biochem Behav; 2015 Jan; 128():8-13. PubMed ID: 25444864
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular microinjection of the 5-HT
Shahidi S; Sadeghian R; Komaki A; Asl SS
Pharmacol Biochem Behav; 2018 Oct; 173():27-35. PubMed ID: 30077744
[TBL] [Abstract][Full Text] [Related]
3. Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior.
Su HL; Zhu J; Chen YJ; Zhao N; Han W; Dang YH; Xu M; Chen T
Physiol Behav; 2013 Jun; 118():195-200. PubMed ID: 23711566
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of vesicular glutamate transporters contributes to attenuate methamphetamine-induced conditioned place preference in rats.
He Z; Chen Y; Dong H; Su R; Gong Z; Yan L
Behav Brain Res; 2014 Jul; 267():1-5. PubMed ID: 24613241
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of methamphetamine and cocaine on conditioned place preference and locomotor activity in adult and adolescent male rats.
Zakharova E; Leoni G; Kichko I; Izenwasser S
Behav Brain Res; 2009 Mar; 198(1):45-50. PubMed ID: 18996417
[TBL] [Abstract][Full Text] [Related]
6. Streptozotocin-induced diabetes affects the development and maintenance of morphine reward in rats.
Samandari R; Chizari A; Hassanpour R; Mousavi Z; Haghparast A
Neurosci Lett; 2013 May; 543():90-4. PubMed ID: 23545208
[TBL] [Abstract][Full Text] [Related]
7. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
[TBL] [Abstract][Full Text] [Related]
8. Conditioned place preference following concurrent treatment with 3, 4-methylenedioxypyrovalerone (MDPV) and methamphetamine in male and female Sprague-Dawley rats.
Risca HI; Zuarth-Gonzalez JD; Baker LE
Pharmacol Biochem Behav; 2020 Nov; 198():173032. PubMed ID: 32888971
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.
Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
Pharmacol Biochem Behav; 2007 May; 87(1):48-55. PubMed ID: 17482247
[TBL] [Abstract][Full Text] [Related]
10. Reinstatement of methamphetamine conditioned place preference in nicotine-sensitized rats.
Berry JN; Neugebauer NM; Bardo MT
Behav Brain Res; 2012 Dec; 235(2):158-65. PubMed ID: 22884606
[TBL] [Abstract][Full Text] [Related]
11. Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls.
Riddle JL; Rokosik SL; Napier TC
Behav Brain Res; 2012 Jul; 233(1):15-23. PubMed ID: 22727039
[TBL] [Abstract][Full Text] [Related]
12. Involvement of mitogen-stimulated p70-S6 kinase in the development of sensitization to the methamphetamine-induced rewarding effect in rats.
Narita M; Akai H; Kita T; Nagumo Y; Narita M; Sunagawa N; Hara C; Hasebe K; Nagase H; Suzuki T
Neuroscience; 2005; 132(3):553-60. PubMed ID: 15837117
[TBL] [Abstract][Full Text] [Related]
13. Genetic deletion of the MT1 or MT2 melatonin receptors abrogates methamphetamine-induced reward in C3H/HeN mice.
Clough SJ; Hutchinson AJ; Hudson RL; Dubocovich ML
Physiol Behav; 2014 Jun; 132():79-86. PubMed ID: 24813704
[TBL] [Abstract][Full Text] [Related]
14. Gabapentin blocks methamphetamine-induced sensitization and conditioned place preference via inhibition of α₂/δ-1 subunits of the voltage-gated calcium channels.
Kurokawa K; Shibasaki M; Mizuno K; Ohkuma S
Neuroscience; 2011 Mar; 176():328-35. PubMed ID: 21182903
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.
Itzhak Y; Martin JL; Ali SF
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1177-83. PubMed ID: 12452543
[TBL] [Abstract][Full Text] [Related]
16. The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice.
Fujita Y; Kunitachi S; Iyo M; Hashimoto K
Pharmacol Biochem Behav; 2012 Apr; 101(2):303-6. PubMed ID: 22260872
[TBL] [Abstract][Full Text] [Related]
17. A selective D3 receptor antagonist YQA14 attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.
Sun L; Song R; Chen Y; Yang RF; Wu N; Su RB; Li J
Acta Pharmacol Sin; 2016 Feb; 37(2):157-65. PubMed ID: 26687935
[TBL] [Abstract][Full Text] [Related]
18. The circadian gene, Per2, influences methamphetamine sensitization and reward through the dopaminergic system in the striatum of mice.
Kim M; Custodio RJ; Botanas CJ; de la Peña JB; Sayson LV; Abiero A; Ryoo ZY; Cheong JH; Kim HJ
Addict Biol; 2019 Sep; 24(5):946-957. PubMed ID: 30091820
[TBL] [Abstract][Full Text] [Related]
19. Differential Roles of Intra-accumbal Orexin Receptors in Acquisition and Expression of Methamphetamine-Induced Conditioned Place Preference in the Rats.
Khosrowabadi E; Karimi-Haghighi S; Jamali S; Haghparast A
Neurochem Res; 2020 Sep; 45(9):2230-2241. PubMed ID: 32643036
[TBL] [Abstract][Full Text] [Related]
20. Effect of a 5-HT
Shahidi S; Komaki A; Sadeghian R; Soleimani Asl S
Brain Res; 2018 Nov; 1698():151-160. PubMed ID: 30076792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
